GINAKIT Cells
Sponsors
Baylor College of Medicine
Conditions
Neuroblastoma
Phase 1
3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
WithdrawnNCT02439788
Start: 2017-08-31End: 2030-10-31Updated: 2017-06-14
GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma
RecruitingNCT03294954
Start: 2018-01-18End: 2040-08-10Target: 70Updated: 2025-09-19